There is no written testing program designed to assess the stability characteristics of drug products.
Inspection Record
University of Washington Medical Center Inpatient Pharmacy — FDA 483 Findings
Inspectors Gerard P. De Leon · Gloria J. Baca · Erica D. ButlerThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile do not include adequate validation of the sterilization process.
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established or followed.
Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
Aseptic processing areas are deficient regarding systems for maintaining any equipment used to control the aseptic conditions.
Each batch of drug product purporting to be sterile is not laboratory tested to determine conformance to such requirements.
Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room and equipment to produce aseptic conditions.
Clothing of personnel engaged in the manufacturing and processing of drug products is not appropriate for the duties they perform.
About this record
Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
